Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-28

Clinical Trial Update: Atopic Dermatitis (AD) and Food Allergy

View source ↗

Summary

The NIAID-sponsored clinical trial NCT03168113 investigating Atopic Dermatitis (AD) with non-atopic healthy controls has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis (AD), Non-atopic Healthy Controls | Status: COMPLETED